A gift from Dialysis Clinic, Inc., in honor of a longtime professor of nephrology will be used to fund the DCI Edwin A. Rutsky, M.D., Distinguished Endowed Chair in Nephrology in the UAB School of Medicine.
This mass spectrometry method can locate where molecular changes occur in a thin slice of tissue, and it has broad applicability to biomedical research.
This protective effect on cardiotoxicity could benefit cancer chemotherapy recipients and heart failure patients.
Treating patients 50 and older with high blood pressure to a systolic blood pressure of less than 120 mm Hg reduced rates of cardiovascular events, including heart attack, heart failure and stroke, by 25 percent.
Blood tests in obese African-American teenage girls reveal immune system changes which ‘prime the system’ to develop cardiovascular disease later in life.
Lower blood pressure target of 120 mm Hg greatly reduces cardiovascular complications and deaths in older adults.
Doctors at UAB are developing new ways to increase the number of living donors via the Incompatible Kidney Transplant Program.
UAB professors who developed a new area of translational cardio-renal research are among 15 professors identified as today’s leaders in the field.
David Pollock, Ph.D., professor in the Division of Nephrology, recently visited Cuba with a delegation from the American Physiological Society to sign a historic agreement for research collaboration with leaders of the Cuban Society of Physiological Sciences.
UAB will receive funding from the AHA over the next four years to complete projects in population health, clinical and basic science, focused on high blood pressure.